Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Neither 25(OH)D nor VDBP levels predicted exacerbation rate, change in fat free mass index or risk of death.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
The patients were recruited during stable state, and active autoimmune diseases or cancer within the last 5 years were cause for exclusion.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Vitamin D, Vitamin D Binding Protein, and Longitudinal Outcomes in COPD
Study design awaiting verification · PLoS ONE · 2015
Original publication title
Vitamin D, Vitamin D Binding Protein, and Longitudinal Outcomes in COPD
© 2015 Persson et al
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Associations between Vitamin D3 [25(OH)D], vitamin D binding protein (VDBP) and chronic obstructive pulmonary disease (COPD) are previously reported. We aimed to further investigate these associations on longitudinal outcomes.
Source: BackgroundAbstract: What methods does the paper describe?
426 COPD patients from western Norway, GOLD stage II-IV, aged 40 to 76, were followed every six-month from 2006 through 2009 with spirometry, bioelectrical impedance measurements and registration of exacerbation frequency. Serum 25(OH)D and VDBP levels were determined at study-entry by high-performance liquid chromatography coupled with mass spectrometry and enzyme immunoassays respectively. Yearly change in lung function and body composition was assessed by generalized estimating equations (GEE), yearly exacerbation rate by negative binomial regression models, and 5 years all-cause mortality by Cox proportional-hazard regression.
Source: MethodsAbstract: Results
1/3 of the patients had vitamin D deficiency (<20ng/mL) and a greater decline in both FEV1 and FVC, compared to patients with normal levels; for FEV1 this difference only reached statistical significance in the 28 patients with the lowest levels (<10ng/mL, p = 0.01). Neither 25(OH)D nor VDBP levels predicted exacerbation rate, change in fat free mass index or risk of death.
Source: ResultsAbstract: Conclusion
Severe vitamin D deficiency may affect decline in lung function parameters in COPD. Neither 25(OH)D nor VDBP levels did otherwise predict markers of disease progression.
Source: ConclusionAuthors’ abstract
Background
Associations between Vitamin D3 [25(OH)D], vitamin D binding protein (VDBP) and chronic obstructive pulmonary disease (COPD) are previously reported. We aimed to further investigate these associations on longitudinal outcomes.
Methods
426 COPD patients from western Norway, GOLD stage II-IV, aged 40 to 76, were followed every six-month from 2006 through 2009 with spirometry, bioelectrical impedance measurements and registration of exacerbation frequency. Serum 25(OH)D and VDBP levels were determined at study-entry by high-performance liquid chromatography coupled with mass spectrometry and enzyme immunoassays respectively. Yearly change in lung function and body composition was assessed by generalized estimating equations (GEE), yearly exacerbation rate by negative binomial regression models, and 5 years all-cause mortality by Cox proportional-hazard regression.
Results
1/3 of the patients had vitamin D deficiency (<20ng/mL) and a greater decline in both FEV1 and FVC, compared to patients with normal levels; for FEV1 this difference only reached statistical significance in the 28 patients with the lowest levels (<10ng/mL, p = 0.01). Neither 25(OH)D nor VDBP levels predicted exacerbation rate, change in fat free mass index or risk of death.
Conclusion
Severe vitamin D deficiency may affect decline in lung function parameters in COPD. Neither 25(OH)D nor VDBP levels did otherwise predict markers of disease progression.
Publication and source details
Original title: Vitamin D, Vitamin D Binding Protein, and Longitudinal Outcomes in COPD
Louise J. P. Persson; Marianne Aanerud; Pieter S. Hiemstra; Annika E. Michelsen; Thor Ueland; Jon A. Hardie; Pål Aukrust; Per S. Bakke; Tomas M. L. Eagan
PLoS ONE · 2015
Competing Interests: Louise J. P. Persson reports having received lecture fees from GlaxoSmithKline within the last 5 years. Jon A. Hardie reports having received lecture fees from GlaxoSmithKline, AstraZeneca, and Boehringer-Ingelheim within the last 5 years. Per S. Bakke reports having received lecture fees from GlaxoSmithKline, Nycomed, Pfizer, and Boehringer-Ingelheim within the last 5 years. Tomas M. Eagan reports having received lecture fees from GlaxoSmithKline and Boehringer-Ingelheim, and financial support from InterMune for conference travels within the last 5 years.
Marianne Aanerud, Pieter S. Hiemstra, Pål Aukrust, Thor Ueland, and Annika E. Michelsen have nothing to disclose. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Conceived and designed the experiments: TMLE PSB JAH PSH PA TU. Performed the experiments: AEM TMLE LJPP PSB JAH MA. Analyzed the data: LJPP TMLE. Contributed reagents/materials/analysis tools: TMLE PSB JAH PSH PA TU AEM. Wrote the paper: LJPP TMLE PSB MA PSH. Interpreted the data: PSB MA JAH PSH TU PA LJPP TMLE. Revised and approved the final manuscript: LJPP TMLE PSB MA JAH PSH PA TU AEM.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T10:13:23.795948+00:00
DOI: 10.1371/journal.pone.0121622 · PMC4372215